Intra-tumoural regulatory T cells: A potential new target in cancer immunotherapy
- 12 May 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 343 (3) , 684-691
- https://doi.org/10.1016/j.bbrc.2006.03.018
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The Therapeutic Implications of Intratumoral Regulatory T CellsClinical Cancer Research, 2005
- Advances in the diagnosis, evaluation, and management of malignant pleural mesotheliomaRespirology, 2005
- Natural regulatory T cells in infectious diseaseNature Immunology, 2005
- CD4+CD25high regulatory T cells in human pregnancyJournal of Reproductive Immunology, 2005
- Mini‐review: Overcoming tumor‐intrinsic resistance to immune effector functionEuropean Journal of Immunology, 2004
- Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritisEuropean Journal of Immunology, 2003
- Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic CellsThe Journal of Experimental Medicine, 2002
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancerEuropean Journal Of Cancer, 1999
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsPublished by Elsevier ,1994